Signed in as:
filler@godaddy.com
Signed in as:
filler@godaddy.com
The cannabis plant contains a large number of naturally occurring compounds known as cannabinoids. Among the most widely recognised are cannabidiol (CBD) and tetrahydrocannabinol (THC), along with a growing number of minor cannabinoids such as CBG, CBN, and CBC, which continue to be explored through ongoing research. The plant also contains aromatic compounds known as terpenes, which may contribute to the way cannabinoid formulations are experienced within the body.
These cannabinoids interact with the body’s endocannabinoid system in different ways and may influence signalling pathways involved in mood, sleep, stress response, pain perception, appetite, inflammation, nervous system regulation, and overall wellbeing.

CBD is generally regarded as non-intoxicating and does not typically produce the psychoactive effects associated with THC. Research continues to explore how CBD may influence inflammatory pathways, nervous system regulation, stress responses, sleep, and neurotransmitter signalling involved in mood and emotional wellbeing.
CBD-containing therapies are often considered a longer-acting cannabinoid approach and may be explored within broader and individualised treatment plans, particularly where a more balanced or non-intoxicating cannabinoid profile may be appropriate. Some individuals may also explore CBD-based therapies alongside other supportive strategies aimed at improving overall wellbeing and quality of life.
Although CBD is generally considered to have a lower risk of impairment compared with THC-containing therapies, responses can still vary between individuals, and patients should always follow current medical advice and driving regulations relevant to their state or territory.

THC is the primary psychoactive cannabinoid found within the cannabis plant and interacts predominantly with CB1 receptors located throughout the brain and central nervous system. THC may influence pain perception, appetite, nausea pathways, sleep, mood, sensory perception, and muscle tension.
Compared with CBD, THC-containing therapies are often considered to have a shorter and more immediate effect profile, and some individuals may explore these therapies for support with symptoms experienced more acutely or at particular times of the day or night.
For some individuals, THC-containing therapies may play a supportive role within carefully monitored treatment plans. However, THC may also produce side effects or unwanted psychoactive effects in some people, particularly at higher doses or in more sensitive individuals.
THC may also affect cognition, coordination, reaction time, and perception. Patients should be aware that THC-containing therapies may have implications for driving, workplace safety, and the operation of machinery, and should always follow current medical advice and relevant laws and regulations within their state or territory..

In addition to CBD and THC, the cannabis plant contains a growing number of minor cannabinoids that are receiving increasing scientific and clinical interest. Although present in smaller amounts, these compounds may contribute to the broader effects of cannabinoid-based therapies and are being explored for their potential role in supporting nervous system regulation, sleep, mood, inflammation, gut function, and overall wellbeing.
Research into minor cannabinoids is still evolving, and understanding of their individual and combined effects continues to develop.
CBG is often referred to as the “parent” cannabinoid, as many other cannabinoids are derived from its precursor form during plant development. Early research is exploring how CBG may influence inflammatory pathways, nervous system signalling, mood regulation, and gut function.
Some clinicians and patients are increasingly interested in how CBG may contribute to broader cannabinoid formulations, particularly when combined with other cannabinoids as part of an individualised approach to care.
CBN is a cannabinoid formed as THC naturally ages and breaks down over time. It is currently being explored for its possible interactions with sleep regulation, nervous system relaxation, and restorative wellbeing.
Although research remains limited, some individuals and clinicians have shown growing interest in how CBN-containing formulations may complement broader cannabinoid approaches, particularly in evening or nighttime treatment plans.
CBC is another non-intoxicating cannabinoid receiving increasing scientific attention for its potential influence on inflammation, nervous system signalling, and mood-related pathways.
Research into CBC remains in relatively early stages, however there is ongoing interest in how it may contribute to the broader balance and interaction of cannabinoid-based therapies.
THCV is a naturally occurring minor cannabinoid receiving growing scientific interest for its unique interaction with the endocannabinoid system. Although structurally similar to THC, THCV appears to interact differently with cannabinoid receptors and may produce distinct effects depending on dose and individual response.
Emerging research is exploring how THCV may influence pathways involved in metabolism, energy regulation, appetite signalling, and glucose balance, leading to increasing interest in its potential role within broader metabolic health research. Like many cannabinoids, THCV may also contribute differently when combined alongside other cannabinoids and terpenes within balanced formulations.
CBDA is the naturally occurring acidic precursor to CBD found within the raw cannabis plant before heating or processing occurs. Although research into CBDA is still in relatively early stages, growing scientific interest is exploring how it may interact with pathways involved in inflammation, nausea regulation, nervous system signalling, and neurological function.
Early research is continuing to investigate the potential role of CBDA within broader cannabinoid formulations and its interaction with the endocannabinoid system. Like many cannabinoids, CBDA may contribute differently when combined alongside other cannabinoids and terpenes within balanced and individualised therapeutic approaches.
CBDV is a naturally occurring cannabinoid structurally related to CBD and is receiving increasing scientific interest for its potential interaction with neurological and nervous system pathways. Although research remains in relatively early stages, CBDV is being explored within broader investigations into neurodevelopmental, sensory, and neurological regulation.
As with many cannabinoids, understanding of CBDV continues to evolve, particularly regarding how it may interact alongside other cannabinoids and terpenes within balanced and individualised formulations.

The cannabis plant also contains naturally occurring aromatic compounds known as terpenes. Terpenes are found widely throughout nature and are responsible for the distinctive scents and flavours of many plants, including lavender, citrus fruits, pine, herbs, and flowers.
Within cannabinoid-based therapies, terpenes are receiving increasing scientific interest for the way they may interact with cannabinoids and the body’s endocannabinoid system. Research continues to explore how terpenes may influence mood, nervous system regulation, alertness, relaxation, inflammation, and overall wellbeing. Some commonly discussed terpenes include:
Myrcene is one of the more commonly occurring terpenes within cannabis and is also found in plants such as mango, hops, and lemongrass. It is often associated with calming or relaxing properties and is being explored for its possible influence on sleep, muscle relaxation, and overall nervous system regulation.
Limonene is a citrus-scented terpene found naturally in fruits such as lemons and oranges. Research continues to explore how limonene may influence mood, stress responses, and emotional wellbeing, with interest in its potentially uplifting or balancing properties.
Pinene is a terpene commonly found in pine trees, rosemary, and eucalyptus. It is being explored for its possible influence on alertness, memory, respiratory function, and inflammation-related pathways.
Linalool is also found in lavender and is often associated with calming and relaxing properties. Ongoing research is exploring how linalool may interact with pathways involved in stress regulation, sleep, and nervous system balance.
Cannabinoids and terpenes do not work in isolation and may interact together in complex and potentially complementary ways within the body. This is sometimes referred to as the “entourage effect,” where multiple plant compounds — including minor cannabinoids and terpenes — may contribute meaningfully to how a formulation is experienced by an individual.
Responses to cannabinoid-based therapies can vary significantly between people, influenced by factors such as genetics, underlying health conditions, nervous system sensitivity, lifestyle, concurrent medications, and the balance of cannabinoids and terpenes within a medicine.
Research into cannabinoids, terpenes, and the endocannabinoid system continues to evolve rapidly. While scientific understanding and clinical experience continue to expand, there is still much to learn about the complexity of these interactions and their long-term role within healthcare.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.